Home » Impax Drug Demonstrates Efficacy and Safety in Phase III Study
Impax Drug Demonstrates Efficacy and Safety in Phase III Study
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., Thursday announced positive top-line results of the APEX-PD Phase III clinical study with IPX066 in Parkinson’s disease.
FreshNews
FreshNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May